Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
03/2007
03/21/2007EP1439176B1 Pyrimidone compounds and pharmaceutical compositions containing the same
03/21/2007EP1401826B1 Pyrazole derivatives as hiv reverse transcriptase inhibitors
03/21/2007EP1345943B1 Inhibitors of papilloma virus
03/21/2007EP1112270B1 Dihydrobenzodioxine carboxamide and ketone derivatives as 5-ht4 receptor antagonists
03/21/2007CN1934115A Diastereoselective epoxidation of allylically substituted alkenes using metalloporphyrin catalysts
03/21/2007CN1934103A Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
03/21/2007CN1934101A Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
03/21/2007CN1934100A Substituted quinazoline or pyridopyrimidine derivative
03/21/2007CN1934097A Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
03/21/2007CN1934094A Diaryl-substituted five-membered heterocycle derivative
03/21/2007CN1934091A Imidazole compounds for the treatment of neurodegenerative disorders
03/21/2007CN1934088A 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
03/21/2007CN1934087A Novel phenantridine analogues and their uses as inhibitors of hyperproliferation of T cells and/or keratinocytes
03/21/2007CN1934083A 2,7-substituted 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octan amide derivatives as renin inhibitors for the treatment of hypertension
03/21/2007CN1934081A Novel benayl(idene)-lactam derivatives
03/21/2007CN1933839A Compounds and methods of use
03/21/2007CN1933838A Bipyridyl amides as modulators of metabotropic glutamate receptor-5
03/21/2007CN1933830A Indole derivatives and use thereof as kinase inhibitors in particular ik. k.2 inhibitors
03/21/2007CN1931827A 2- and 2,5-substituted phenylketo-enols
03/21/2007CN1305872C Process for producing quinazoline ditosylate salt compounds
03/21/2007CN1305871C Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders
03/21/2007CN1305853C Process for the manufacture of HMG-coa reductase inhibitors
03/21/2007CN1305852C Diaryl ethers as opioid receptor antagonist
03/21/2007CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
03/21/2007CN1305847C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
03/20/2007US7193080 Color photography
03/20/2007US7193065 activated haptens useful for generating immunogens to HIV protease inhibitors
03/20/2007US7192979 EP4 receptor selective agonist in the treatment of osteoporosis
03/20/2007US7192978 Pyrrolidinium derivatives
03/20/2007US7192976 3-substituted pyrazoles; cell proliferation and angiogenesis promoters; antiapoptotosis and antifibrosis activity
03/20/2007US7192973 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5)
03/20/2007US7192971 4-Heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein
03/20/2007US7192961 1-Carbonyl-4-(4-quinoline-)-piperazine or 1-carbonyl-4-[4-(1H-quinolin-2-{thio}one)-piperazine derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment
03/20/2007US7192960 Sodium channel blockers
03/20/2007US7192955 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/20/2007US7192953 Antibacterial agents
03/20/2007US7192950 Psychological disorders; eating disorders; dietetics
03/20/2007US7192944 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
03/20/2007CA2211320C 5-methanesulfonamido-3h-isobenzofuran-1-ones as inhibitors of cyclooxygenase-2
03/15/2007WO2007029847A1 Bicyclic aromatic substituted pyridone derivative
03/15/2007WO2007029587A1 β SECRETASE INHIBITOR
03/15/2007WO2007029216A1 Preparation of an atorvastatin intermediate
03/15/2007WO2007029156A2 Isoindoledione derivatives as adrenergic receptor antagonists
03/15/2007WO2006138528A3 Tricyclic opioid modulators
03/15/2007WO2006128692A3 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system
03/15/2007US20070060754 Alkoxy substituted imidazoquinolines
03/15/2007US20070060629 Large conductance calcium-activated k channel opener
03/15/2007US20070060624 Novel bioisosteres of actinonin
03/15/2007US20070060619 Nicotinamide-based kinase inhibitors
03/15/2007US20070060616 Methods for treating, preventing and managing chronic lymphocytic leukemia with indazole compounds
03/15/2007US20070060583 2-tert-Butyl-N,N-diethyl-1-{[1-methylpiperidin-2-yl]methyl}-1H-benzimidazole-5-carboxamide; cannabinoid receptors agonists; analgesic, anticarcinogenic, antiinflammatory, anxiolytic agent; neurodegenerative diseases; gastrointestinal and cardiovascular disorders
03/15/2007US20070060582 1,4-Disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases
03/15/2007US20070060570 Sulfopyrroles
03/15/2007US20070060569 Azacycloalkyl substituted acetic acid derivatives for use as MMP inhibitors
03/15/2007US20070060566 Benzazepine derivatives as histamine h3 antagonists
03/15/2007CA2621506A1 Preparation of an atorvastatin intermediate
03/15/2007CA2621470A1 Bicyclic aromatic substituted pyridone derivative
03/15/2007CA2620491A1 Pharmaceutical dosage forms and compositions comprising lecoztan
03/14/2007EP1762567A1 Pyrazole derivatives for treating HIV
03/14/2007EP1761531A1 Imidazole variants as modulators of gaba receptor for the treatment of gi disorders
03/14/2007EP1761524A1 Phenyl diazepane carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine d3 antagonists
03/14/2007EP1761522A1 Compounds and methods for treating dyslipidemia
03/14/2007EP1761519A1 Indole derivatives as histamine receptor antagonists
03/14/2007EP1761506A1 Substituted quinazolones as anti-cancer agents
03/14/2007EP1761505A1 Pyrimidine urea derivatives as kinase inhibitors
03/14/2007EP1761500A1 Pesticidal n-phenylpyrazole derivatives
03/14/2007EP1761497A2 Azadecalin glucocorticoid receptor modulators
03/14/2007EP1761491A1 Novel piperidine/8-azabicyclo [3.2.1] octan derivatives as moduilators of chemokine receptor ccr5
03/14/2007EP1040103B1 Anilide derivative, production and use thereof
03/14/2007CN1930173A Process for preparing cephalosporin intermediates using alpha-iodo-1-azetidineacetic acid esters and trialkylphosphites
03/14/2007CN1930152A 1,3-dioxane derivatives and analogues thereof useful in the treatment of I.A. obesity and diabetes
03/14/2007CN1930144A 3-'4-heterocyclyl -1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases
03/14/2007CN1930135A Diaminopyrimidines as P2X3 and P2X2/3 antagonists
03/14/2007CN1930126A 吡啶酮衍生物 Pyridine derivatives
03/14/2007CN1929848A Benzodiazepines for treating or preventing or preventing RSV infection
03/14/2007CN1929738A Substituted 4-(4-trifluoromethylpyrazolyl)-pyrimidines serving as herbicides
03/14/2007CN1304390C Novel gamma secretase inhibitors
03/14/2007CN1304388C Process for synthesizing chiral N-aryl piperazines
03/14/2007CN1304377C Metalloproteinase inhibitors
03/14/2007CN1304374C Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition
03/14/2007CN1303998C Pharmaceutical formulations containing darifenacin
03/13/2007US7189861 Ball milling any crystalline form of atorvastatin hemi-calcium to obtain a polymorphic crystal structure with small particle size distribution; monodispersity; improved physical properties of filtration/drying characteristics, flowability, vapor impermeability, solubility; drug-releasing design
03/13/2007US7189758 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma
03/13/2007US7189757 Sleep disorders; side effect reduction
03/13/2007US7189756 Pyrrolidine derivatives
03/13/2007US7189745 For use in therapy of diseases, in a mammal, in which inappropriate, excessive or undesirable angiogenesis has occurred and/or where excessive Tie2 receptor activity has occurred, cytokine antagonist, antiarthritic agent, for therapy of diabetic retinopathy
03/13/2007US7189741 Indolylpiperidine derivatives as antihistaminic and antiallergic agents
03/13/2007US7189734 Anilinoquinazaolines as protein tyrosine kianse inhibitors
03/13/2007US7189728 Inhibitors of dipeptidyl peptidase IV
03/13/2007US7189724 For therapy of viral diseases
03/13/2007US7189719 Sodium channel blockers
03/13/2007US7189718 viricides; polymerase inhibitor; therapy for genetic engineered viruses
03/13/2007US7189714 Administering quinoline derivative as analgesic
03/13/2007US7189519 Identifying bound modified g-protein coupled receptors assemblies; microarrays; drug screening; colorimetric analysis
03/13/2007CA2351049C Process for recovery of the desired cis-1,3-oxathiolane nucleosides from their undesired trans-isomers
03/13/2007CA2274592C Pyrazole derivatives
03/13/2007CA2176181C D4t polymorphic form i process
03/08/2007WO2007027959A1 Novel benzopyran derivatives as potassium channel openers
03/08/2007WO2007027780A2 Benzopyran and pyranopyridine derivatives as potassium channel openers
03/08/2007WO2007026664A1 Sulfonamide compound